Skip to main content
Clinical Trials/CTRI/2024/08/072028
CTRI/2024/08/072028
Not yet recruiting
未知

To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of reduction inhyperpigmentation, skin glow and skin radiance on healthy female subjects. - NI

Onesto Labs Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Onesto Labs Pvt. Ltd.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Onesto Labs Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • 1\.Indian female subjects.
  • 2\.Healthy subjects
  • 3\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).
  • 4\.Having hyperpigmentation (Acne PIH) dark spot

Exclusion Criteria

  • Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • Having refused to give her assent by signing the consent form.
  • Taking part in another study liable to interfere with this study.
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area.
  • Being insulin\-dependent diabetic or non\-insulin\-dependent diabetic with a recent therapy (less
  • than 6 months).
  • Having a progressive asthma (either under treatment or last fit in the last 2 years).
  • Being epileptic.
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6
  • Having cutaneous hypersensitivity

Outcomes

Primary Outcomes

Not specified

Similar Trials